Avacta Therapeutics Revenue

Biotechnology Research • London, England, United Kingdom • 21-50 Employees

Avacta Therapeutics revenue & valuation

Annual revenue	$11,700,000
Revenue per employee	$278,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$37,300,000
Total funding	No funding

Key Contact at Avacta Therapeutics

Christina Coughlin

Chief Executive Officer

Company overview

Headquarters	London, England, United Kingdom
Phone number	+446605196
Website	avacta.com
NAICS	541714
SIC	873
Keywords	Afinnity Reagents, Antibody Alternatives, Custom Antibody Alternative
Founded	2012
Employees	21-50
Socials

Avacta Therapeutics Email Formats

Avacta Therapeutics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@avacta.com), used 64% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@avacta.com	72%
{first name}.{last name}	john.doe@avacta.com	24%
{first initial}{last name}	jdoe@avacta.com	4%

About Avacta Therapeutics

Avacta is a clinical stage biotechnology company expanding the reach of highly potent cancer therapies with the pre|CISION® platform.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

C-Suite

Employees by Department

Avacta Therapeutics has 12 employees across 8 departments.

Departments

Number of employees

Funding Data

Avacta Therapeutics has never raised funding before.

Avacta Therapeutics Tech Stack

Discover the technologies and tools that power Avacta Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Gravity Forms

Form builders

AddToAny Share Buttons

WordPress plugins

PWA

Miscellaneous

Wistia

Video players

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

Frequently asked questions

Avacta Therapeutics is located in London, England, GB.

You can reach Avacta Therapeutics at +446605196.

Avacta Therapeutics generates an estimated annual revenue of $11,636,163. This revenue figure reflects the company's market position and business performance in its industry.

Avacta Therapeutics has an estimated valuation of $37,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Avacta Therapeutics was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Avacta Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Avacta Therapeutics

Christina Coughlin

Chief Executive Officer

4.8

40,000 users